Metabolic Syndrome Increases Mortality Risk in Dialysis Patients: A Systematic Review and Meta-Analysis

Authors Information
Article Notes and Dates
To Cite : Upala S, Sanguankeo A. Metabolic Syndrome Increases Mortality Risk in Dialysis Patients: A Systematic Review and Meta-Analysis, Int J Endocrinol Metab. Online ahead of Print ;In Press(In Press):e61201. doi: 10.5812/ijem.61201.
Copyright: Copyright © 0, International Journal of Endocrinology and Metabolism. .
Abstract
1. Background
2. Materials and Methods
3. Results
4. Discussion
Acknowledgements
References
  • 1. Grundy SM, Hansen B, Smith SJ, Cleeman JI, Kahn RA, American Heart A, et al. Clinical management of metabolic syndrome: report of the American Heart Association/National Heart, Lung, and Blood Institute/American Diabetes Association conference on scientific issues related to management. Circulation. 2004;109(4):551-6. doi: 10.1161/01.CIR.0000112379.88385.67. [PubMed: 14757684].
  • 2. Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation. 2009;120(16):1640-5. doi: 10.1161/CIRCULATIONAHA.109.192644. [PubMed: 19805654].
  • 3. Chandalia M, Abate N. Metabolic complications of obesity: inflated or inflamed?. J Diabetes Complications. 2007;21(2):128-36. doi: 10.1016/j.jdiacomp.2006.10.004. [PubMed: 17331862].
  • 4. Collins AJ. Cardiovascular mortality in end-stage renal disease. Am J Med Sci. 2003;325(4):163-7. [PubMed: 12695721].
  • 5. Kwan BC, Murtaugh MA, Beddhu S. Associations of body size with metabolic syndrome and mortality in moderate chronic kidney disease. Clin J Am Soc Nephrol. 2007;2(5):992-8. doi: 10.2215/CJN.04221206. [PubMed: 17702712].
  • 6. Abbott KC, Glanton CW, Trespalacios FC, Oliver DK, Ortiz MI, Agodoa LY, et al. Body mass index, dialysis modality, and survival: analysis of the United States Renal Data System Dialysis Morbidity and Mortality Wave II Study. Kidney Int. 2004;65(2):597-605. doi: 10.1111/j.1523-1755.2004.00385.x. [PubMed: 14717930].
  • 7. Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA. 2000;283(15):2008-12. [PubMed: 10789670].
  • 8. Expert Panel on Detection E, Treatment of High Blood Cholesterol in A. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA. 2001;285(19):2486-97. [PubMed: 11368702].
  • 9. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute scientific statement: Executive Summary. Crit Pathw Cardiol. 2005;4(4):198-203. [PubMed: 18340209].
  • 10. Tan CE, Ma S, Wai D, Chew SK, Tai ES. Can we apply the National Cholesterol Education Program Adult Treatment Panel definition of the metabolic syndrome to Asians?. Diabetes Care. 2004;27(5):1182-6. [PubMed: 15111542].
  • 11. Saely CH, Koch L, Schmid F, Marte T, Aczel S, Langer P, et al. Adult Treatment Panel III 2001 but not International Diabetes Federation 2005 criteria of the metabolic syndrome predict clinical cardiovascular events in subjects who underwent coronary angiography. Diabetes Care. 2006;29(4):901-7. [PubMed: 16567835].
  • 12. Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med. 1998;15(7):539-53. doi: 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S. [PubMed: 9686693].
  • 13. Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010;25(9):603-5. doi: 10.1007/s10654-010-9491-z. [PubMed: 20652370].
  • 14. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327(7414):557-60. doi: 10.1136/bmj.327.7414.557. [PubMed: 12958120].
  • 15. Sterne JA, Egger M. Funnel plots for detecting bias in meta-analysis: guidelines on choice of axis. J Clin Epidemiol. 2001;54(10):1046-55. [PubMed: 11576817].
  • 16. Park JT, Chang TI, Kim DK, Lee JE, Choi HY, Kim HW, et al. Metabolic syndrome predicts mortality in non-diabetic patients on continuous ambulatory peritoneal dialysis. Nephrol Dial Transplant. 2010;25(2):599-604. doi: 10.1093/ndt/gfp498. [PubMed: 19783598].
  • 17. Prasad N, Sinha A, Gupta A, Sharma RK, Kaul A, Bhadauria D, et al. Effect of metabolic syndrome on clinical outcomes of non-diabetic peritoneal dialysis patients in India. Nephrology (Carlton). 2013;18(10):657-64. doi: 10.1111/nep.12124. [PubMed: 23834643].
  • 18. Vogt BP, Souza PL, Minicucci MF, Martin LC, Barretti P, Caramori JT. Metabolic syndrome criteria as predictors of insulin resistance, inflammation and mortality in chronic hemodialysis patients. Metab Syndr Relat Disord. 2014;12(8):443-9. doi: 10.1089/met.2014.0011. [PubMed: 25099153].
  • 19. Wu CC, Liou HH, Su PF, Chang MY, Wang HH, Chen MJ, et al. Abdominal obesity is the most significant metabolic syndrome component predictive of cardiovascular events in chronic hemodialysis patients. Nephrol Dial Transplant. 2011;26(11):3689-95. doi: 10.1093/ndt/gfr057. [PubMed: 21357211].
  • 20. Xie Q, Zhang AH, Chen SY, Lai X, Zhang F, He L, et al. Metabolic syndrome is associated with better nutritional status, but not with cardiovascular disease or all-cause mortality in patients on haemodialysis. Arch Cardiovasc Dis. 2012;105(4):211-7. doi: 10.1016/j.acvd.2012.01.012. [PubMed: 22633295].
  • 21. Yang SY, Chiang CK, Hsu SP, Peng YS, Pai MF, Ho TI, et al. Metabolic syndrome predicts hospitalization in hemodialysis patients: a prospective Asian cohort study. Blood Purif. 2007;25(3):252-9. doi: 10.1159/000101698. [PubMed: 17429199].
  • 22. Johnson DW, Armstrong K, Campbell SB, Mudge DW, Hawley CM, Coombes JS, et al. Metabolic syndrome in severe chronic kidney disease: Prevalence, predictors, prognostic significance and effects of risk factor modification. Nephrology (Carlton). 2007;12(4):391-8. doi: 10.1111/j.1440-1797.2007.00804.x. [PubMed: 17635756].
  • 23. Liao CT, Kao TW, Chou YH, Wu MS, Chen YM, Chuang HF, et al. Associations of metabolic syndrome and its components with cardiovascular outcomes among non-diabetic patients undergoing maintenance peritoneal dialysis. Nephrol Dial Transplant. 2011;26(12):4047-54. doi: 10.1093/ndt/gfr175. [PubMed: 21565947].
  • 24. Bossola M, Giungi S, Tazza L, Luciani G. Is there any survival advantage of obesity in Southern European haemodialysis patients?. Nephrol Dial Transplant. 2010;25(1):318-9. author reply 319. doi: 10.1093/ndt/gfp543. [PubMed: 19892755].
  • 25. Yen TH, Lin JL, Lin-Tan DT, Hsu CW. Association between body mass and mortality in maintenance hemodialysis patients. Ther Apher Dial. 2010;14(4):400-8. doi: 10.1111/j.1744-9987.2010.00818.x. [PubMed: 20649761].
  • 26. Abbott KC, Oliver DK, Hurst FP, Das NP, Gao SW, Perkins RM. Body mass index and peritoneal dialysis: "exceptions to the exception" in reverse epidemiology?. Semin Dial. 2007;20(6):561-5. doi: 10.1111/j.1525-139X.2007.00347.x. [PubMed: 17991205].
  • 27. Fouque D, Kalantar-Zadeh K, Kopple J, Cano N, Chauveau P, Cuppari L, et al. A proposed nomenclature and diagnostic criteria for protein-energy wasting in acute and chronic kidney disease. Kidney Int. 2008;73(4):391-8. doi: 10.1038/sj.ki.5002585. [PubMed: 18094682].
  • 28. Weber MA, Neutel JM, Smith DH. Contrasting clinical properties and exercise responses in obese and lean hypertensive patients. J Am Coll Cardiol. 2001;37(1):169-74. [PubMed: 11153733].
  • 29. Schrier RW, Abraham WT. Hormones and hemodynamics in heart failure. N Engl J Med. 1999;341(8):577-85. doi: 10.1056/NEJM199908193410806. [PubMed: 10451464].
  • 30. Foley RN, Parfrey PS, Sarnak MJ. Epidemiology of cardiovascular disease in chronic renal disease. J Am Soc Nephrol. 1998;9(12 Suppl):S16-23. [PubMed: 11443763].
  • 31. Czernichow S, Kengne AP, Stamatakis E, Hamer M, Batty GD. Body mass index, waist circumference and waist-hip ratio: which is the better discriminator of cardiovascular disease mortality risk?: evidence from an individual-participant meta-analysis of 82 864 participants from nine cohort studies. Obes Rev. 2011;12(9):680-7. doi: 10.1111/j.1467-789X.2011.00879.x. [PubMed: 21521449].
  • 32. Chen HY, Tsai WC, Chiu YL, Hsu SP, Pai MF, Yang JY, et al. Triglyceride to high-density lipoprotein cholesterol ratio predicts cardiovascular outcomes in prevalent dialysis patients. Medicine (Baltimore). 2015;94(10). e619. doi: 10.1097/MD.0000000000000619. [PubMed: 25761189].
  • 33. Shortreed SM, Peeters A, Forbes AB. Estimating the effect of long-term physical activity on cardiovascular disease and mortality: evidence from the Framingham Heart Study. Heart. 2013;99(9):649-54. doi: 10.1136/heartjnl-2012-303461. [PubMed: 23474622].
  • 34. Jha V, Rathi M. Dialysis: low-glucose-containing peritoneal dialysis solutions: good or bad?. Nat Rev Nephrol. 2013;9(11):635-6. doi: 10.1038/nrneph.2013.205. [PubMed: 24080795].
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Cited By: